Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 May 1;304(9):E934-43.
doi: 10.1152/ajpendo.00039.2013. Epub 2013 Mar 12.

Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial

Affiliations
Randomized Controlled Trial

Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial

Julia Johansson et al. Am J Physiol Endocrinol Metab. .

Abstract

Acupuncture has been demonstrated to improve menstrual frequency and to decrease circulating testosterone in women with polycystic ovary syndrome (PCOS). Our aim was to investigate whether acupuncture affects ovulation frequency and to understand the underlying mechanisms of any such effect by analyzing LH and sex steroid secretion in women with PCOS. This prospective, randomized, controlled clinical trial was conducted between June 2009 and September 2010. Thirty-two women with PCOS were randomized to receive either acupuncture with manual and low-frequency electrical stimulation or to meetings with a physical therapist twice a week for 10-13 wk. Main outcome measures were changes in LH secretion patterns from baseline to after 10-13 wk of treatment and ovulation frequency during the treatment period. Secondary outcomes were changes in the secretion of sex steroids, anti-Müllerian hormone, inhibin B, and serum cortisol. Ovulation frequency during treatment was higher in the acupuncture group than in the control group. After 10-13 wk of intervention, circulating levels of estrone, estrone sulfate, estradiol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, androstenedione, testosterone, free testosterone, dihydrotestosterone, androsterone glucuronide, androstane-3α,17β-diol-3-glucuronide, and androstane-3α,17β-diol-17-glucuronide decreased within the acupuncture group and were significantly lower than in the control group for all of these except androstenedione. We conclude that repeated acupuncture treatments resulted in higher ovulation frequency in lean/overweight women with PCOS and were more effective than just meeting with the therapist. Ovarian and adrenal sex steroid serum levels were reduced with no effect on LH secretion.

Trial registration: ClinicalTrials.gov NCT00921492.

Keywords: acupuncture; lh pulsatility; ovulation; polycystic ovary syndrome; sex steroids.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow of participants through the trial. All participants assigned to acupuncture or attention control treatment and who underwent baseline assessments were included in the intention-to-treat analysis.
Fig. 2.
Fig. 2.
Ovulation frequency during treatment. Frequency is expressed as ovulations per month ± SD in women with polycystic ovary syndrome (PCOS) during 10–13 wk of acupuncture or attention control treatment. **P < 0.01 vs. attention control.
Fig. 3.
Fig. 3.
Changes in the area under the curve from baseline to end of treatment for sex steroids, sex steroid precursors, and glucuronidated androgen metabolites in women with PCOS after 10–13 wk of acupuncture or attention control treatment. Values are shown as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 vs. attention control before Bonferroni correction.

References

    1. Anonymous. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23: 462–477, 2008 - PubMed
    1. Ahmed MI, Duleba AJ, El Shahat O, Ibrahim ME, Salem A. Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Hum Reprod 23: 2564–2569, 2008 - PubMed
    1. Arroyo A, Laughlin GA, Morales AJ, Yen SS. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82: 3728–3733, 1997 - PubMed
    1. Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu JK, Vale WW, Rivier JE, Judd HL. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 56: 897–903, 1983 - PubMed
    1. Chu MC, Carmina E, Wang J, Lobo RA. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 84: 1685–1688, 2005 - PubMed

Publication types

MeSH terms

Associated data